As of 2025-08-08, the Relative Valuation of Taro Pharmaceutical Industries Ltd (TARO) is 31.10 USD. This relative valuation is based on P/E multiples. With the latest stock price at 42.97 USD, the upside of Taro Pharmaceutical Industries Ltd based on Relative Valuation is -27.6%.
The range of the Relative Valuation is 20.78 - 41.92 USD.
| Range | Selected | |
| Trailing P/E multiples | 14.5x - 22.6x | 16.5x |
| Forward P/E multiples | 16.6x - 20.3x | 18.6x |
| Fair Price | 20.78 - 41.92 | 31.10 |
| Upside | -51.6% - -2.4% | -27.6% |
| Date | P/E |